Drug Shortage Report for TADALAFIL

Last updated on 2023-12-26 History
Report ID 200477
Drug Identification Number 02457016
Brand name TADALAFIL
Common or Proper name TADALAFIL
Company Name SANIS HEALTH INC
Market Status MARKETED
Active Ingredient(s) TADALAFIL
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 28
ATC code G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-07-31
Estimated end date 2023-12-13
Actual end date 2023-12-15
Shortage status Resolved
Updated date 2023-12-26
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1 PRESIDENTS CHOICE CIRCLE
BRAMPTON, ONTARIO
CANADA L6Y 5S5
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2023-12-26 French Compare
v12 2023-12-26 English Compare
v11 2023-12-01 French Compare
v10 2023-12-01 English Compare
v9 2023-11-22 French Compare
v8 2023-11-22 English Compare
v7 2023-10-23 French Compare
v6 2023-10-23 English Compare
v5 2023-08-22 French Compare
v4 2023-08-22 English Compare
v3 2023-08-01 English Compare
v2 2023-07-31 French Compare
v1 2023-07-31 English Compare

Showing 1 to 13 of 13